Trials / Sponsors / Access to Advanced Health Institute (AAHI)

Access to Advanced Health Institute (AAHI)

Academic / Other · 16 registered clinical trials.

Status	Trial	Phase	Started
Completed	Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults Pulmonary TB	Phase 1	2018-10-02
Completed	Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers Leprosy	Phase 1	2017-10-02
Completed	Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion Pulmonary Tuberculosis	Phase 2	2015-06-01
Completed	Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers Visceral Leishmaniasis	Phase 1	2014-04-01
Completed	Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers Pulmonary Tuberculosis	Phase 1	2013-09-01
Completed	H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers Influenza A Subtype H5N1 Infection	Phase 1	2012-09-01
Completed	The Effects of GLA (5 mcg) on Human Volunteers Healthy Volunteers	Phase 1	2012-09-01
Completed	Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers Pulmonary Tuberculosis	Phase 1	2012-08-01
Completed	Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers Leishmaniasis	Phase 1	2012-01-01
Completed	A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis Cutaneous Leishmaniasis	Phase 2	2009-10-01
Completed	Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDL Post Kala Azar Dermal Leishmaniasis	Phase 1	2009-04-01
Completed	Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in Indi Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis	Phase 1	2007-04-01
Completed	Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healt Cutaneous Leishmaniasis	Phase 1	2005-08-01
Completed	Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Paras Cutaneous Leishmaniasis	Phase 2	2005-08-01
Completed	Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis Leishmaniasis, Cutaneous	Phase 1	2004-10-01
Completed	Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis Leishmaniasis, Mucocutaneous	Phase 1	2004-07-01